Orthofix Medical Inc. Shareholders' Equity
Orthofix Medical Inc. (OFIX) had Shareholders' Equity of $429.18 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $429.18M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $435.19M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $450.04M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $442.49M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $429.18M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $435.19M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $450.04M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $442.49M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $458.35M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $458.29M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $503.12M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $525.92M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $546.00M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $570.32M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $598.73M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $615.48M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $639.99M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $664.16M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $336.86M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $333.54M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $341.95M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $335.57M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $336.93M 10-K · filed 2025-02-25 | |
| 2021-09-30 | $364.83M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $362.28M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $354.82M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $356.86M 10-K · filed 2024-03-05 | |
| 2020-09-30 | $354.90M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $345.05M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $355.37M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $327.63M 10-K · filed 2023-03-06 | |
| 2019-09-30 | $306.43M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $347.79M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $343.68M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $335.40M 10-K · filed 2022-02-25 | |
| 2018-09-30 | $323.35M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $319.85M 10-Q · filed 2019-10-28 | |
| 2018-03-31 | $313.17M 10-Q · filed 2019-10-28 | |
| 2017-12-31 | $296.61M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $285.31M 10-Q · filed 2017-10-30 | |
| 2017-06-30 | $276.95M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $267.13M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $263.48M 10-K · filed 2020-02-24 | |
| 2016-09-30 | $273.18M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $258.23M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $275.47M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $290.31M 10-K · filed 2019-02-25 | |
| 2015-09-30 | $297.21M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $297.68M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $290.54M 10-Q · filed 2015-05-18 | |
| 2014-12-31 | $299.63M 10-K · filed 2018-02-26 | |
| 2014-09-30 | $305.02M 10-K · filed 2015-04-29 | |
| 2014-06-30 | $305.21M 10-K · filed 2015-04-29 | |
| 2014-03-31 | $300.56M 10-K · filed 2015-04-29 | $317.26M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $295.86M 10-K · filed 2017-02-27 | $310.49M 10-K · filed 2014-03-31 |
| 2013-09-30 | $306.99M 10-K · filed 2015-04-29 | $319.06M 10-Q · filed 2014-03-25 |
| 2013-06-30 | $332.15M 10-K · filed 2015-04-29 | $345.23M 10-Q · filed 2014-03-24 |
| 2013-03-31 | $360.98M 10-K · filed 2015-04-29 | $402.17M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $356.44M 10-K · filed 2016-02-29 | $399.10M 10-K · filed 2013-03-01 |
| 2012-09-30 | $332.42M 10-K/A · filed 2015-03-31 | $377.61M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $312.92M 10-K/A · filed 2015-03-31 | $354.22M 10-Q · filed 2012-07-30 |
| 2012-03-31 | $298.55M 10-K/A · filed 2015-03-31 | $338.41M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $280.30M 10-K/A · filed 2015-03-31 | $315.17M 10-K · filed 2012-02-29 |
| 2011-09-30 | $292.09M 10-K/A · filed 2014-03-24 | $310.94M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $279.98M 10-K/A · filed 2014-03-24 | $297.91M 10-Q · filed 2011-08-05 |
| 2011-03-31 | $263.99M 10-K/A · filed 2014-03-24 | |
| 2010-12-31 | $300.89M 10-K · filed 2012-02-29 | |
| 2009-12-31 | $240.27M 10-K · filed 2012-02-29 | |
| 2008-12-31 | $202.06M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |